Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital, provided comments to Reuters Health about study findings examining the use of rivaroxaban plus aspirin for patients with vascular disease and moderate renal dysfunction. Dr. Bashir was not involved in the original COMPASS trial or the secondary study. MD Alert picked up the Reuters Health piece.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH